Standard BioTools Inc. (FRA:FLB)

Market Cap	509.14M
Revenue (ttm)	144.67M
Net Income (ttm)	-109.31M
Shares Out	n/a
EPS (ttm)	-0.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	7
Open	1.080
Previous Close	1.060
Day's Range	1.080 - 1.080
52-Week Range	0.805 - 1.980
Beta	n/a
RSI	58.53
Earnings Date	Feb 6, 2026

About Standard BioTools

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates in two segments, Proteomics and Genomics. Its proteomics and genomics include instruments, consumables, software, and services based upon technologies used in the identification of proteins, as well as genes and their functions. The company provide...

• Industry: Laboratory Analytical Instruments
• Founded: 1999
• Employees: 818
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FLB

Financial Performance

In 2024, Standard BioTools's revenue was $174.43 million, an increase of 64.03% compared to the previous year's $106.34 million. Losses were -$184.90 million, 147.7% more than in 2023.

Financial numbers in USD